Welcome to our dedicated page for Innerscope Hear news (Ticker: INND), a resource for investors and traders seeking the latest updates and insights on Innerscope Hear stock.
InnerScope Hearing Technologies, Inc. (INND) is a technology-driven company based in Roseville, California, offering scalable B2B and B2C solutions. The company provides a B2B SAAS-based Patient Management System software program that improves operations and communication with patients. They also offer a buying group experience for audiology practices to lower product costs and increase margins. INND competes in the Direct-to-Consumer markets with 'hearable,' 'wearable,' personal sound amplification products (PSAP). Revolutionary apps on iOS and Android markets cater exclusively to the hearing impairment population globally, tapping into a vast untapped market created by the recent OTC (Over-the-Counter) hearing aids ruling.
InnerScope Hearing Technologies (OTC: INND) has launched its HearingAssist brand of FDA-Registered OTC Rechargeable Hearing Aids on Walgreens.com. This strategic move is part of InnerScope's B2B sales growth strategy, allowing them to reach millions of Walgreens customers. The HearingAssist Rechargeable OTC Hearing Aids, priced between $499 and $799, promise affordability and high-quality features, including Bluetooth connectivity. With over 500,000 hearing aids sold, InnerScope aims to dominate the OTC market by enhancing access to effective hearing solutions.
InnerScope Hearing Technologies (OTC: INND) has launched its HearingAssist brand of FDA-registered Over-the-Counter (OTC) rechargeable hearing aids on Walgreens.com, expanding its market reach. This launch grants nationwide access to consumers seeking affordable hearing solutions, with prices ranging from $499 to $799 per pair. InnerScope claims to be America's #1 OTC hearing aid brand, having sold over 500,000 units. The new hearing aids feature advanced technology such as Bluetooth connectivity, enabling users to stream audio from smartphones. InnerScope's strategy focuses on increasing B2B sales through major retailers, positioning itself as a leader in the OTC hearing aid market.
InnerScope Hearing Technologies (OTC: INND) reported a profitable year-end 2022, highlighting consolidated net revenues of $15,284,327, gross profit of $9,079,335, and a net profit of $5,575,892. The company's EBITA stood at 36%, demonstrating strong operational efficiency. Driven by wholesale distribution agreements from its acquisitions of HearingAssist and iHEAR, InnerScope expanded its market presence significantly. In line with the FDA ruling enabling OTC hearing aids' sale without a prescription, InnerScope pivoted to a B2B model, enhancing its retail partnerships. The annual financial report is available on OTC Markets.
InnerScope Hearing Technologies (OTC: INND) has announced the launch of its HearingAssist brand of FDA-Registered Over-the-Counter (OTC) Rechargeable Hearing Aids on Target.com. This expansion aims to reach nearly 30 million Americans in need of hearing solutions. The HearingAssist devices are priced between $499 and $599, featuring Bluetooth technology and advanced sound enhancement capabilities. With over 500,000 hearing aids sold, InnerScope is positioned as a leader in the affordable OTC hearing aid market, benefitting from the recent OTC Hearing Aid Law. The launch on Target strengthens its market distribution through major retailers.
InnerScope Hearing Technologies Inc. (OTC: INND) has launched its HearingAssist Rechargeable OTC Hearing Aids on CVS.com and in select CVS locations across Massachusetts and Rhode Island. The products, which offer advanced features including Bluetooth capabilities at a competitive price of $499, aim to enhance accessibility to affordable hearing solutions. This launch follows a recent introduction of the iHEAR brand on CVS.com, aimed at increasing market presence in the OTC hearing aid sector and is part of InnerScope's broader distribution strategy.
InnerScope Hearing Technologies Inc. (OTC: INND) has signed a Memorandum of Understanding (MOU) with NUHEARA Limited (ASX: NUH) to integrate NUHEARA's FDA-cleared self-fitting OTC hearing aid technology into its own hearing aids. This partnership grants InnerScope exclusive rights to distribute NUHEARA's products in the US, expanding both companies' market presence. NUHEARA's HP Hearing PRO, featuring self-fitting technology, will be marketed through InnerScope’s distribution network, enhancing accessibility to affordable hearing solutions. Products are expected to ship by early February 2023.
FAQ
What is the current stock price of Innerscope Hear (INND)?
What is the market cap of Innerscope Hear (INND)?
What does InnerScope Hearing Technologies do?
What kind of software program does INND provide?
How does INND benefit audiology practices?
What markets does INND compete in?
What is the untapped market created for INND?
What apps does INND offer for iOS and Android markets?
What is the latest product launch by INND?
Where can customers find INND products?
What is the competitive advantage of INND products?
How does INND plan to expand its brand recognition?
What are the benefits of iHEAR Matrix Rechargeable OTC Hearing Aids?
